The most common cause of skin and soft tissue infections is Staphylococcus; Methicillin-resistant Staphylococcus aureus (MRSA) ranges from 22.8% in Europe to 59% in the USA2
Current laboratory methods can take up to 72 hours to determine if a SSTI is Staphylococcus aureus (SA) or MRSA2
SSTIs require early recognition and prompt management as, depending on their severity, they can lead to considerable morbidity and mortality (3,4%) and represent a major economic burden to the healthcare system estimated to €7,778 per patient with 18,5 days of mean length of hospital stay2,3
The use of inappropriate initial antibiotic treatment can be associated with adverse clinical outcomes, increased morbidity and mortality, and increased hospital LOS or costs3
The initial empiric treatment has to be changed in around 40% of patients following the diagnostic results2
The Solution
A fast and comprehensive SSTI test:
Xpert MRSA/SA SSTI is a comprehensive SA test:
Includes targets for S. aureus, MRSA, and mecA
Identifies presumptive positive “empty cassette” strains for correct classification as SA sensitive
Unparalleled automation with the GeneXpert® System provides reduced hands-on time and improved laboratory efficiency
The Impact
Important healthcare benefits of rapid detection:1
Helps ensure the right therapy sooner for improved patient management
Enables a targeted antimicrobial therapy approach for better antimicrobial stewardship
Allows for immediate identification of patient infection for improved isolation and infection control measures